Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2021-04-27
Summary
This study observes the effects of newly developed direct-acting antiviral (DAA) treatments on the central nervous system (CNS) of individuals with chronic Hepatitis C (HCV). The goals of this study are to determine the CNS impact of curing chronic HCV disease with newly established DAA therapies and how HIV alters this relationship.
Conditions
- Hepatitis C
- Human Immunodeficiency Virus
Sponsors & Collaborators
-
University of California, San Diego
lead OTHER
Principal Investigators
-
Ajay Bharti, M.D. · UCSD
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
Transforming the Cascade Of Hepatitis C Care
NCT03226509 ·Status: COMPLETED
-
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
NCT00788918 ·Status: COMPLETED ·Phase: NA
-
Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment
NCT02648022 ·Status: COMPLETED ·Phase: NA
-
Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults
NCT01472354 ·Status: COMPLETED ·Phase: NA
-
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915 ·Status: COMPLETED
-
Anticipated and Perceived Benefits Following Hepatitis C Treatment
NCT03000023 ·Status: COMPLETED
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability
NCT01265693 ·Status: COMPLETED
-
Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy
NCT02469012 ·Status: UNKNOWN ·Phase: NA
-
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
NCT03894696 ·Status: UNKNOWN
-
Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
NCT03268317 ·Status: UNKNOWN
-
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
NCT00136214 ·Status: COMPLETED
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
NCT00655226 ·Status: TERMINATED ·Phase: NA
-
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
NCT02294136 ·Status: COMPLETED ·Phase: NA
-
Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
NCT03508115 ·Status: COMPLETED
-
Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients
NCT03057236 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hepatitis C in Psychiatric Patients
NCT00751426 ·Status: COMPLETED
-
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
NCT03993925 ·Status: ACTIVE_NOT_RECRUITING
-
Hepatitis C Treatment in Underserved Populations
NCT01717560 ·Status: UNKNOWN ·Phase: NA
-
Study on the Prevalence of Hepatitis C In a psychiatRic Population
NCT04600479 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
NCT01143896 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
NCT00674492 ·Status: COMPLETED
-
Risk of HCC in Cirrhotic Patients Post DAAs Ttt
NCT03414554 ·Status: UNKNOWN